MORGAN STANLEY - LAVA THERAPEUTICS NV ownership

LAVA THERAPEUTICS NV's ticker is LVTX and the CUSIP is N51517105. A total of 19 filers reported holding LAVA THERAPEUTICS NV in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of LAVA THERAPEUTICS NV
ValueSharesWeighting
Q3 2023$15,141
-26.9%
10,300
+1.0%
0.00%
Q2 2023$20,706
+40.2%
10,200
+14.6%
0.00%
Q1 2023$14,774
-39.6%
8,900
+27.3%
0.00%
Q4 2022$24,469
+6.4%
6,991
+39.8%
0.00%
Q3 2022$23,000
+35.3%
5,000
-12.3%
0.00%
Q2 2022$17,000
+41.7%
5,700
+103.6%
0.00%
Q1 2022$12,000
-50.0%
2,800
-35.3%
0.00%
Q4 2021$24,0004,3250.00%
Other shareholders
LAVA THERAPEUTICS NV shareholders Q1 2022
NameSharesValueWeighting ↓
Bruce & Co., Inc. 771,874$1,150,0920.39%
Novo Holdings A/S 2,400,000$3,528,0000.26%
Redmile Group, LLC 2,074,372$3,090,8140.15%
Alpha Wave Global, LP 109,097$162,5550.10%
Artal Group S.A. 200,000$2940.01%
Tower Research Capital LLC (TRC) 11,960$17,5810.00%
OSAIC HOLDINGS, INC. 48$710.00%
PNC FINANCIAL SERVICES GROUP, INC. 65,000$95,5500.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 100$1490.00%
View complete list of LAVA THERAPEUTICS NV shareholders